PuSH - Publikationsserver des Helmholtz Zentrums München

Maares, M.* ; Haupt, A.* ; Schüßler, C.* ; Kulike-Koczula, M.* ; Hackler, J.* ; Keil, C.* ; Mohr, I.* ; Schomburg, L.* ; Süssmuth, R.D.* ; Zischka, H. ; Merle, U.* ; Haase, H.*

Correction to: A fluorometric assay to determine labile copper(II) ions in serum (Scientific Reports, (2023), 13, 1, (12807), 10.1038/s41598-023-39841-9).

Sci. Rep. 14:8859 (2024)
Erratum DOI PMC
Open Access Hybrid
Creative Commons Lizenzvertrag
Correction to: Scientific Reportshttps://doi.org/10.1038/s41598-023-39841-9, published online 07 August 2023 The original version of this Article contained errors in Figure 4c. The values for ‘Storage temperature’, displayed on the X-axis, were inadvertently changed into the mean values of the depicted bars. The original Figure 4 and accompanying legend appear below. (Figure presented.) Stability of labile Cu2+ in serum. Repeatability and reproducibility of the assay are shown, including relative standard deviation (RSD) (a). Labile Cu2+ concentration in the reference serum depending on the number of freeze–thaw cycles (b) and storage temperature (c) are depicted. The labile Cu2+ concentration in 1% human reference serum upon spiking with 0 or 20 nM CuSO4 (N = 4) is presented (d). Statistically significant differences between labile Cu2+ values were determined with non-parametric Kruskal–Wallis with Dunn’s multiple comparison test (b), ordinary one way ANOVA followed by Tukey multiple comparison test (c), and unpaired t-test (*p < 0.05, **p < 0.01; ***p < 0.001). Results are presented as data points including mean ± SD of at least three independent experiments. The original Article has been corrected.
Altmetric
Tags
Anmerkungen
Besondere Publikation
Auf Hompepage verbergern

Zusatzinfos bearbeiten
Eigene Tags bearbeiten
Privat
Eigene Anmerkung bearbeiten
Privat
Auf Publikationslisten für
Homepage nicht anzeigen
Als besondere Publikation
markieren
Publikationstyp Sonstiges: Korrektur, Ergänzung
Sprache englisch
Veröffentlichungsjahr 2024
HGF-Berichtsjahr 2024
ISSN (print) / ISBN 2045-2322
e-ISSN 2045-2322
Zeitschrift Scientific Reports
Quellenangaben Band: 14, Heft: 1, Seiten: , Artikelnummer: 8859 Supplement: ,
Verlag Nature Publishing Group
Verlagsort London
Begutachtungsstatus Peer reviewed
POF Topic(s) 30203 - Molecular Targets and Therapies
Forschungsfeld(er) Enabling and Novel Technologies
PSP-Element(e) G-505200-003
Scopus ID 85190516082
PubMed ID 38632369
Erfassungsdatum 2024-04-23